Market Place
Sourcing Support
All News #Library
Biotech
Alpha Tau Treats First EU Pancreatic Cancer Patient with DaRT
23 Apr 2026 //
GLOBENEWSWIRE
Alpha Tau Expands Alpha Dart Trial To Pancreatic Cancer
23 Apr 2026 //
GLOBENEWSWIRE
Alpha Tau Presents DaRT Pancreatic Cancer Data at DDW 2026
31 Mar 2026 //
GLOBENEWSWIRE
Alpha Tau To Present At Sidoti March Virtual Small Cap Conference
16 Mar 2026 //
GLOBENEWSWIRE
Japan Approves Alpha DaRT for Head & Neck Cancer
24 Feb 2026 //
GLOBENEWSWIRE
Alpha Tau`s Letter To Shareholders Highlights Five U.S. Trials
29 Jan 2026 //
GLOBENEWSWIRE
Alpha Tau Presents DaRT Study Results at 2026 ASCO GI Symposium
06 Jan 2026 //
GLOBENEWSWIRE
Alpha Tau Submits First Alpha DaRT PMA for cSCC Carcinoma to FDA
05 Jan 2026 //
GLOBENEWSWIRE
Alpha Tau To Present At J.P. Morgan 2026 Healthcare Conference
18 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau Treats First U.S. Recurrent Glioblastoma Patient
09 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau To Present Two Alpha Dart Pancreatic Cancer Abstracts
04 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau Wins FDA Nod for Locally Recurrent Prostate Cancer
02 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau Unveils Q3 2025 Financials And Corporate Update
20 Nov 2025 //
GLOBENEWSWIRE
Alpha Tau Gets Radioactive License For New Manufacturing Site
21 Oct 2025 //
GLOBENEWSWIRE
Alpha Tau Treats First U.S. Patient in Pancreatic Cancer Trial
02 Sep 2025 //
GLOBENEWSWIRE
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
25 Mar 2024 //
GLOBENEWSWIRE
Former Commissioner of FDA Stephen M. Hahn Appointed to Alpha Tau Advisory Board
24 Oct 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.